Chapter 1. CONTROLLED RELEASE DRUG DELIVERY MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. CONTROLLED RELEASE DRUG DELIVERY MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. CONTROLLED RELEASE DRUG DELIVERY MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. CONTROLLED RELEASE DRUG DELIVERY MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. CONTROLLED RELEASE DRUG DELIVERY MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. CONTROLLED RELEASE DRUG DELIVERY MARKET– By Technology

6.1. Wurster Technique

6.2. Coacervation

6.3. Micro Encapsulation

6.4. Implants

6.5. Transdermal

6.6. Targeted Delivery

6.7. Others (Microelectromechanical Technology, Liposomes)

Chapter 7. CONTROLLED RELEASE DRUG DELIVERY MARKET– By Release Mechanism

7.1. Polymer Based Systems

7.2. Micro Reservoir Partition Controlled Drug Delivery Systems

7.3. Feedback Regulated Drug Delivery Systems

7.4. Activation-modulated Drug Delivery Systems

      7.4.1. Osmotic Pressure Activated

      7.4.2. Hydrodynamic Pressure Activated

      7.4.3. Vapor Pressure Activated

      7.4.4. Mechanically Activated

      7.4.5. Magnetically Activated

7.5. Chemically Activated

      7.5.1. pH Activated

      7.5.2. Hydrolysis Activated

      7.5.3. Enzyme Activated

Chapter 8. CONTROLLED RELEASE DRUG DELIVERY MARKET– By Application

8.1. Metered Dose Inhalers

8.2. Injectable

8.3. Transdermal and Ocular Patches

8.4. Infusion Pumps

8.5. Oral Controlled-drug delivery Systems

8.6. Drug Eluting Stents

Chapter 9. CONTROLLED RELEASE DRUG DELIVERY MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. CONTROLLED RELEASE DRUG DELIVERY MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10

Download Sample